The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

The agency said that the test is unnecessary for the screening of whole blood and blood components that are screened with nucleic acid tests and core antigen tests.

The US Food and Drug Administration granted clearances for infectious disease tests, digital pathology software, and hematology analyzers, among other in vitro diagnostic technologies.

The rapid lateral flow assay from Lumos Diagnostics distinguishes bacterial and nonbacterial respiratory infections using a drop of blood.

NEW YORK – The US Food and Drug Administration in June granted 510(k) marketing clearances for infectious disease tests, digital pathology software, and hematology analyzers, among others in vitro ...

The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate ...

Agilent Technologies said that Robert McMahon will resign from as the company's senior vice president and chief financial officer, effective July 31 for family reasons. Rodney Gonsalves, Agilent's ...

The Determine Antenatal Care Panel is used for the simultaneous detection of infectious diseases that threaten maternal and pediatric health.

The partnership will initially focus on low-abundance biomarkers supporting translational research in Alzheimer's disease.